Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Silk Road Medical
(NASDAQ:SILK)
Intraday
$21.03
0
[0.00%]
After-Hours
$21.03
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$21.03
0
[0.00%]
At close: May 10
$21.03
0
[0.00%]
PreMarket: 4:00PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Silk Road Medical Stock (NASDAQ:SILK)
Silk Road Medical Stock (NASDAQ: SILK)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, May 01, 2024
Evaluating Silk Road Medical: Insights From 6 Financial Analysts
Benzinga Insights
-
May 1, 2024, 1:00PM
JP Morgan Maintains Neutral on Silk Road Medical, Raises Price Target to $21
Benzinga Newsdesk
-
May 1, 2024, 11:01AM
Piper Sandler Maintains Neutral on Silk Road Medical, Raises Price Target to $20
Benzinga Newsdesk
-
May 1, 2024, 9:42AM
Tuesday, April 30, 2024
Silk Road Medical Sees FY24 Revenue $194M-$198M Vs $195.923M Est.
Benzinga Newsdesk
-
Apr 30, 2024, 5:07PM
Silk Road Medical Q1 2024 GAAP EPS $(0.36) Beats $(0.40) Estimate, Sales $48.484M Beat $44.676M Estimate
Benzinga Newsdesk
-
Apr 30, 2024, 4:28PM
Friday, March 08, 2024
Reported Earlier, Genesis MedTech Collaborates With Silk Road Medical To Combat Stroke Risk In China With Advanced TCAR Technology
Benzinga Newsdesk
-
Mar 8, 2024, 1:52AM
Thursday, March 07, 2024
Argus Research Upgrades Silk Road Medical to Buy, Announces $24 Price Target
Benzinga Newsdesk
-
Mar 7, 2024, 10:43AM
Tuesday, March 05, 2024
Silk Road Medical Launches Tapered ENROUTE Transcarotid Stent System
Benzinga Newsdesk
-
Mar 5, 2024, 9:05AM
Thursday, February 29, 2024
Breaking Down Silk Road Medical: 5 Analysts Share Their Views
Benzinga Insights
-
Feb 29, 2024, 4:00PM
Stifel Maintains Buy on Silk Road Medical, Raises Price Target to $23
Benzinga Newsdesk
-
Feb 29, 2024, 12:42PM
JP Morgan Maintains Neutral on Silk Road Medical, Raises Price Target to $19
Benzinga Newsdesk
-
Feb 29, 2024, 11:31AM
Top 3 Health Care Stocks You May Want To Dump In Q1
Avi Kapoor
-
Feb 29, 2024, 10:40AM
Piper Sandler Maintains Neutral on Silk Road Medical, Raises Price Target to $18
Benzinga Newsdesk
-
Feb 29, 2024, 8:35AM
Wednesday, February 28, 2024
Silk Road Medical Projects Full Year 2024 Revenue Of $194M-$198M, Est $191.652M
Benzinga Newsdesk
-
Feb 28, 2024, 4:45PM
Silk Road Medical: Q4 Earnings Insights
Benzinga Insights
-
Feb 28, 2024, 4:20PM
Silk Road Medical Q4 2023 GAAP EPS $(0.33) Beats $(0.42) Estimate, Sales $47.27M Beat $41.97M Estimate
Benzinga Newsdesk
-
Feb 28, 2024, 4:15PM
Earnings Scheduled For February 28, 2024
Benzinga Insights
-
Feb 28, 2024, 6:24AM
Tuesday, January 23, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Jan 23, 2024, 4:31PM
Friday, January 19, 2024
Heart Devices Focused Silk Road Medical Stock Gets an Upgrade - Analyst Says New CEO's Initiatives Sets Stage For 'Back On Track'
Vandana Singh
-
Jan 19, 2024, 1:35PM
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Jan 19, 2024, 1:05PM
World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday
Avi Kapoor
-
Jan 19, 2024, 10:20AM
Silk Road Medical shares are trading higher after Stifel upgraded the stock from Hold to Buy and raised its price target from $9 to $20.
Benzinga Newsdesk
-
Jan 19, 2024, 9:21AM
Texas Instruments To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
-
Jan 19, 2024, 7:36AM
Stifel Upgrades Silk Road Medical to Buy, Raises Price Target to $20
Benzinga Newsdesk
-
Jan 19, 2024, 4:49AM
Monday, January 08, 2024
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Jan 8, 2024, 1:36PM
Wednesday, January 03, 2024
Expert Outlook: Silk Road Medical Through The Eyes Of 5 Analysts
Benzinga Insights
-
Jan 3, 2024, 3:00PM
Lake Street Initiates Coverage On Silk Road Medical with Buy Rating, Announces Price Target of $20
Benzinga Newsdesk
-
Jan 3, 2024, 11:45AM
Wednesday, November 08, 2023
Silk Road Sees FY23 Revenue $170M-$174M Vs $171.55M Est
Benzinga Newsdesk
-
Nov 8, 2023, 5:57PM
Recap: Silk Road Medical Q3 Earnings
Benzinga Insights
-
Nov 8, 2023, 4:35PM
Silk Road Medical Q3 EPS $(0.33) Beats $(0.35) Estimate, Sales $44.44M Miss $44.92M Estimate
Benzinga Newsdesk
-
Nov 8, 2023, 4:32PM
Earnings Scheduled For November 8, 2023
Benzinga Insights
-
Nov 8, 2023, 4:21AM
Tuesday, November 07, 2023
Earnings Preview: Silk Road Medical
Benzinga Insights
-
Nov 7, 2023, 12:02PM
Thursday, November 02, 2023
Silk Road Medical Names Chas McKhann Chief Executive Officer
Benzinga Newsdesk
-
Nov 2, 2023, 8:05AM
Tuesday, October 24, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
Benzinga Insights
-
Oct 24, 2023, 11:00AM
8 Analysts Have This to Say About Silk Road Medical
Benzinga Insights
-
Oct 24, 2023, 9:00AM
Wolfe Research Upgrades Silk Road Medical to Peer Perform
Benzinga Newsdesk
-
Oct 24, 2023, 6:19AM
Wednesday, October 11, 2023
Analysts Downgrade Heart Devices Focused Silk Road Medical, Cite Uncertain Prospects
Vandana Singh
-
Oct 11, 2023, 3:24PM
Crude Oil Down 2.5%; Silk Road Medical Shares Plummet
Lisa Levin
-
Oct 11, 2023, 2:52PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Oct 11, 2023, 1:31PM
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Oct 11, 2023, 1:13PM
Dow Turns Lower; Tempest Therapeutics Shares Spike Higher
Lisa Levin
-
Oct 11, 2023, 12:38PM
Piper Sandler Maintains Neutral on Silk Road Medical, Lowers Price Target to $11
Benzinga Newsdesk
-
Oct 11, 2023, 12:04PM
Silk Road Medical shares are trading lower after the company announced preliminary Q3 revenue results below estimates and issued FY23 revenue guidance below estimates.
Benzinga Newsdesk
-
Oct 11, 2023, 11:45AM
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2023
Benzinga Insights
-
Oct 11, 2023, 11:00AM
CL King Downgrades Silk Road Medical to Neutral
Benzinga Newsdesk
-
Oct 11, 2023, 9:41AM
Dow Surges Over 100 Points; US Producer Prices Rise In September
Lisa Levin
-
Oct 11, 2023, 9:40AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Oct 11, 2023, 9:06AM
Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Oct 11, 2023, 8:24AM
Citigroup Downgrades Silk Road Medical to Sell, Lowers Price Target to $8
Benzinga Newsdesk
-
Oct 11, 2023, 6:09AM
B. Riley Securities Downgrades Silk Road Medical to Neutral, Lowers Price Target to $14
Benzinga Newsdesk
-
Oct 11, 2023, 6:03AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch